Two new studies report on the potential of a number of antioxidants and a cholesterol-lowering drug to prevent neurodegeneration in a Drosophila genetic model of parkinsonism. This research shines a spotlight on the power of invertebrate models as an in vivo screening tool.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Angeles, D. C. et al. Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2. Ann. Clin. Transl. Neurol. 3, 288–294 (2016).
Lin, C. H. et al. Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity. Hum. Mol. Genet. http://dx.doi.org/10.1093/hmg/ddw068 (2016).
Whitworth, A. J. Drosophila models of Parkinson's disease. Adv. Genet. 73, 1–50 (2011).
Healy, D. G. et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case–control study. Lancet Neurol. 7, 583–590 (2008).
Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308–1312 (2009).
Smith, W. W. et al. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat. Neurosci. 9, 1231–1233 (2006).
West, A. B. et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl Acad. Sci. USA 102, 16842–16847 (2005).
West, A. B. Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinic. Mov. Disord. 30, 180–189 (2015).
Huang, X. et al. Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. Mov. Disord. 30, 552–559 (2015).
Lin, C. H., Tsai, P. I., Wu, R. M. & Chien, C. T. LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3β. J. Neurosci. 30, 13138–13149 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Martin, I., Chittoor, V. Insect screens for PD therapies — keep the flies in. Nat Rev Neurol 12, 318–319 (2016). https://doi.org/10.1038/nrneurol.2016.56
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2016.56
